Trade

with

Tetraphase Pharmaceuticals Inc
(NASDAQ: TTPH)
AdChoices
23.83
+0.39
+1.66%
After Hours :
-
-
-

Open

23.50

Previous Close

23.44

Volume (Avg)

35.25k (477.55k)

Day's Range

23.50-23.89

52Wk Range

8.01-25.23

Market Cap.

607.56M

Dividend Rate ( Yield )

-

Beta

-

Shares Outstanding

25.95M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 10.49M

    • Net Income

    • -29.64M

    • Market Cap.

    • 607.56M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -685.03

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -

    • Forward P/E

    • -10.27

    • Price/Sales

    • 71.94

    • Price/Book Value

    • 10.41

    • Price/Cash flow

    • -13.68

      • EBITDA

      • -27.79M

      • Return on Capital %

      • -66.71

      • Return on Equity %

      • -88.29

      • Return on Assets %

      • -66.71

      • Book Value/Share

      • 2.25

      • Shares Outstanding

      • 25.95M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 22.50

        • Credit Rating

        • -

        • Analysts

        • 3

        • EPS Estimate

        • -2.33

        • Cashflow Estimate

        • -2.37

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -65.70

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • -

          • 7.80

          • Net Income

            Q/Q (last year)

          • -

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 6.10

          • Net Income

            5-Year Annual Average

          • -

          • 3.73

          • Dividends

            5-Year Annual Average

          • -

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 100.00

            • 69.92

            • Pre-Tax Margin

            • -685.03

            • 21.84

            • Net Profit Margin

            • -685.03

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.05

              • 0.32

              • Current Ratio

              • 4.54

              • 1.92

              • Quick Ratio

              • 4.44

              • 1.31

              • Interest Coverage

              • -36.24

              • 17.64

              • Leverage Ratio

              • 1.35

              • 2.03

              • Book Value/Share

              • 2.25

              • 14.72

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -10.71

                • 22.12

                • P/E Ratio 5-Year High

                • -11.30

                • 193.96

                • P/E Ratio 5-Year Low

                • -2.97

                • 87.26

                • Price/Sales Ratio

                • 73.53

                • 3.75

                • Price/Book Value

                • 10.62

                • 3.75

                • Price/Cash Flow Ratio

                • -13.68

                • 14.03

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -88.29

                        (-)

                      • 17.42

                        (18.66)

                      • Return on Assets %

                        (5-Year Average)

                      • -66.71

                        (-)

                      • 8.45

                        (8.77)

                      • Return on Capital %

                        (5-Year Average)

                      • -73.40

                        (-)

                      • 12.41

                        (13.18)

                      • Income/Employee

                      • -

                      • 90.07k

                      • Inventory Turnover

                      • -

                      • 2.46

                      • Asset Turnover

                      • 0.10

                      • 0.46

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -28.19M
                      Operating Margin
                      -268.83
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -13.68
                      Ownership

                      Institutional Ownership

                      66.38%

                      Top 10 Institutions

                      45.73%

                      Mutual Fund Ownership

                      16.49%

                      Float

                      85.33%

                      5% / Insider Ownership

                      0.91%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Prudential Jennison Health Sciences

                      •  

                        641,015

                      • 0.00

                      • 2.47

                      • iShares Russell 2000 (AU)

                      •  

                        341,163

                      • -0.89

                      • 1.57

                      • Vanguard Total Stock Mkt Idx

                      •  

                        312,295

                      • 0.00

                      • 1.20

                      • Hartford Healthcare Fund

                      •  

                        257,721

                      • 0.00

                      • 0.99

                      • Vanguard Extended Market Index Fund

                      •  

                        160,520

                      • 15.55

                      • 0.62

                      • iShares Russell 2000 Growth

                      •  

                        156,835

                      • -0.45

                      • 0.72

                      • Eventide Gilead Fund

                      •  

                        151,000

                      • 0.00

                      • 0.58

                      • Eventide Healthcare & Life Sciences Fund

                      •  

                        149,900

                      • 0.00

                      • 0.58

                      • Wells Fargo Advantage Small Co Growth

                      •  

                        146,613

                      • 4.76

                      • 0.56

                      • BSO Bio Santé

                      •  

                        140,000

                      • 0.00

                      • 0.54

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Broadfin Capital, LLC

                      •  

                        2,115,747

                      • +5.36%

                      • 8.17

                      • Wellington Management Company, LLP

                      •  

                        1,543,916

                      • -4.28%

                      • 5.96

                      • Fidelity Management and Research Company

                      •  

                        1,357,142

                      • -36.63%

                      • 5.23

                      • Novo A/S

                      •  

                        900,000

                      • 0.00%

                      • 3.47

                      • Awm Investment Company Inc

                      •  

                        810,000

                      • 0.00%

                      • 3.13

                      • PointState Capital LP

                      •  

                        700,000

                      • +11.75%

                      • 2.70

                      • Jennison Associates LLC

                      •  

                        647,146

                      • -10.85%

                      • 2.50

                      • Millennium Management LLC

                      •  

                        617,522

                      • -24.26%

                      • 2.38

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Drug Manufacturers – Major

                      Type

                      Speculative Growth

                      Style

                      -

                      Tetraphase Pharmaceuticals Inc is incorporated under the laws of the State of Delaware on July 7, 2006. The Company is a clinical stage biopharmaceutical company using its proprietary chemistry technology creates novel antibiotics fo...morer serious and life-threatening multi-drug resistant infections. The Company's product candidate eravacycline is a fully synthetic tetracycline derivative. In addition to developing an intravenous formulation of eravacycline, the Company is also developing an oral formulation. The Company's competitors include large pharmaceutical and biotechnology companies, specialty pharmaceutical and generic drug companies. It owned two U.S. patents, six foreign patents, seven pending U.S. patent applications, one pending international application filed under the Patent Cooperation Tr...moreeaty and 46 pending foreign patent applications in Europe and 17 other jurisdictions.lessless

                      Key People

                      Guy Macdonald

                      CEO/Director/President

                      Dr. L. Patrick Gage,PhD

                      Chairman of the Board/Director

                      Mr. David Charles Lubner

                      CFO/Senior VP

                      Ms. Nancy J. Wysenski

                      Director

                      Dr. Jeffrey A. Chodakewitz

                      Director

                      • Tetraphase Pharmaceuticals Inc

                      • 480 Arsenal Street

                      • Watertown, MA 02472

                      • USA.Map

                      • Phone: +1 617 715-3600

                      • Fax: +1 617 926-3557

                      • tphase.com

                      Incorporated

                      2006

                      Employees

                      46

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: